Participated · Seed · Jun 2026

Coast 4C operates a platform that links smallholder seaweed farmers in Southeast Asia with global buyers via traceable and responsible supply chains. The company emphasizes regenerative seaweed production and traceability to support ocean-positive production models. With the newly raised seed capital, Coast 4C intends to scale its platform and expand support for smallholder farmers across the region. The firm has attracted impact and ocean-focused investors, including Hatch Blue, Conservation International Ventures, Potato Impact Partners and others. The World Economic Forum’s Blue Carbon Action Partnership and the APAC Community of 1000 Ocean Startups provided targeted support during the fundraise. Earlier support included investors such as Rumah Group & Foundation. The announcement did not disclose revenue, user metrics, founding year, or valuation.

Participated · Series A · Oct 2023

FarmInsect provides an automated fattening system that enables farmers to manufacture protein‑rich animal feed from insect larvae on their own farms, reducing reliance on imported soy and fishmeal. The startup has operated a pilot plant at the Venture Lab of the Technical University of Munich (FACIT) since 2019. Founded in 2019 by Wolfgang Westermeier and Thomas Kuehn, the company is based in Landshut/Munich. FarmInsect is supported by EU programs and the Bavarian Ministry of Agriculture through the EIP Agri funding program and the EIC Accelerator. The company intends to use the new funds to expand its sales activities and increase production capacity. The business model focuses on on‑farm production of sustainable animal feed via automated systems for farmers. FarmInsect is a Munich-based agritech startup founded in 2019 that produces Black Soldier Fly larvae from regional residues as a protein-feed alternative for animal agriculture. Its core offering combines an automated insect-production machine with an IT platform connected to sensors to guide farmers and address traceability. Larvae can be fed directly or dried for storage, and the process also yields high-quality compost that can improve soil quality. FarmInsect says its solution can save farmers up to 20% of feed costs and reduce dependence on imported soy and fishmeal. The company plans to use recent seed funding to accelerate its mission and to establish its first pilot plant at a large aquaculture farm in Bavaria.

Participated · Series A · Dec 2022

FairSupply (Fair Supply Analytics Pty Ltd), founded in 2019 by Kimberly Randle and Dr. Arne Geschke and based in Sydney, provides an ESG SaaS platform and consultancy that delivers supply-chain visibility and risk analytics. The company has mapped more than 60 billion global supply chains to help clients monitor Scope 3 carbon emissions, modern slavery, biodiversity, and water risk. FairSupply has produced two world firsts: modern slavery footprinting and extinction-risk footprinting. Its platform has analyzed over $750 billion in procurement and investment data for customers including AustralianSuper, the Queensland Investment Corporation, Synergy Energy, and RM Williams. The company has received industry recognition, including Best ESG Provider (Australian Enterprise Awards), Category Innovator (AFR’s Sustainability Leaders), and a Regulation Asia Awards "One to Watch" nod. FairSupply plans to use new funding to launch products and expand into international markets as global ESG reporting regimes tighten.

Participated · Series C · Jun 2022

Proximie operates a centralized “Operating System of the OR” that digitally connects operating rooms and delivers preoperative data, real-time collaborative tools for recording, training and delivering care, and postoperative content management. The platform enables remote collaboration during surgery, content capture and distribution, and supports hospitals in training and clinical workflow. The company intends to use new capital to accelerate development of key products and services, build out a marketplace ecosystem and scale its Operating System of the OR. Proximie has been used in tens of thousands of surgical procedures and deployed in over 500 hospitals across 100 countries on five continents. Financially, the company completed an $80M Series C in this round and has raised $130M in total since inception. Hospitals using Proximie report applying the technology to reduce surgical backlogs after COVID-19, speed surgeon training while containing costs, and create hub-and-spoke models to concentrate expertise and reduce travel time and expense. Proximie provides a platform that combines human expertise with augmented reality (AR), machine learning (ML), artificial intelligence (AI) and advanced telecommunications to create a network of digitised operating and diagnostic rooms. The platform captures, digitises, catalogues and analyses every surgical interaction to support remote collaboration and clinical insight. Founded by Dr. Nadine Hachach-Haram in 2016, the company has seen rapid growth over the prior 12 months. Proximie has conducted over 10,000 surgical interactions across 300 hospitals in more than 40 countries. The company plans to expand its commercial presence in the U.S. and European markets and to implement new technologies while continuing research and development. The raise is intended to support those expansion, technology implementation and R&D efforts.

Led · Series A · Feb 2022

Getlabs operates an at-home phlebotomy service that sends trained, W-2 phlebotomists to patients’ homes to collect blood samples, which are processed by partners including Labcorp, Quest Diagnostics and Sonora Quest. The company charges an out-of-pocket “convenience fee” starting at $25 for in-home draws. Founded in 2018 by Kyle Michelson, Getlabs aims to be the in-person arm of telehealth, offering an API to integrate lab scheduling directly into virtual visits. Since its seed round the startup has hired over 100 phlebotomists, reports turnover below 0.5%, and expanded coverage to serve roughly 45% of the U.S. population (up from about 6% four months prior), with a target of 60% by year-end. The business is focused on scaling its workforce and forming partnerships with telehealth companies to enable hybrid care models and broader clinical testing access. Getlabs provides at-home blood draws by dispatching phlebotomists to patients and sending samples to partner labs such as Labcorp and Quest Diagnostics. The company charges patients a $29–$49 fee for home draws while insurance covers the lab processing as usual. Getlabs raised a $3 million seed round to fund expansion and has run soft launches in Phoenix, Philadelphia, and Dallas. Founder and CEO Kyle Michelson started the company after experiencing the inconvenience of in-person lab draws during Y Combinator. The fully remote company has 37 employees and plans to expand into other home-health verticals. Getlabs aims to integrate with telemedicine providers so patients can receive more care at home and notes that roughly 70% of medical decisions are based on lab results while about 30% of patients skip lab orders due to inconvenience.